Company Filing History:
Years Active: 2014-2024
Title: Wolfgang Brysch: Innovator in Pharmaceutical Solubilization
Introduction
Wolfgang Brysch is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of solubilization methods for poorly soluble compounds. With a total of 10 patents to his name, Brysch's work has had a considerable impact on the development of effective pharmaceutical formulations.
Latest Patents
Among his latest patents, Brysch has developed a method for solubilizing 5-amino-2,3-dihydro-1,4-phthalazinedione. This invention relates to a method for solubilizing this compound or its salts, producing a solubilisate that can be utilized in pharmaceutical dosage forms. The method employs a phosphatidylcholine-based solubilization technique. Additionally, he has patented a method for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents. This invention also utilizes a phosphatidylcholine-based solubilization method, enhancing the bioavailability of these compounds in dietary and pharmaceutical applications.
Career Highlights
Throughout his career, Wolfgang Brysch has worked with several prominent companies, including Metriopharm AG and Athenion AG. His experience in these organizations has allowed him to refine his expertise in pharmaceutical formulations and solubilization techniques.
Collaborations
Brysch has collaborated with notable professionals in his field, including Jörg Von Wegerer and Thomas Martin. These collaborations have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Wolfgang Brysch's innovative approaches to solubilization in pharmaceuticals demonstrate his commitment to improving drug delivery systems. His contributions continue to influence the industry and enhance the effectiveness of various pharmaceutical products.